- Home
- FLXS vs AVTX Comparison
FLXS vs AVTX Comparison
Compare FLXS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLXS | AVTX |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.3M | 248.3M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | FLXS | AVTX |
|---|---|---|
| Price | $38.86 | $15.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $32.29 |
| AVG Volume (30 Days) | 19.7K | ★ 306.4K |
| Earning Date | 02-02-2026 | 03-19-2026 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | ★ 64.53 | N/A |
| EPS | ★ 4.11 | N/A |
| Revenue | ★ $447,505,000.00 | $192,000.00 |
| Revenue This Year | $3.61 | N/A |
| Revenue Next Year | $4.07 | N/A |
| P/E Ratio | $9.37 | ★ N/A |
| Revenue Growth | ★ 6.00 | N/A |
| 52 Week Low | $29.38 | $3.39 |
| 52 Week High | $64.14 | $20.72 |
Technical Indicators
Market Signals| Indicator | FLXS | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.92 | 40.02 |
| Support Level | $38.22 | $14.50 |
| Resistance Level | $42.42 | $17.12 |
| Average True Range (ATR) | 1.67 | 1.02 |
| MACD | -0.34 | -0.07 |
| Stochastic Oscillator | 13.10 | 17.68 |
Price Performance
Historical ComparisonAbout FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).